BiotechTube
Home/NeuroKappa Therapeutics/Gordon Barr, PhD
GB

Gordon Barr, PhD

DMD (likely Director of Medicinal Chemistry)

NeuroKappa Therapeutics

Therapeutic Areas

StrokePain ManagementAddiction TherapyDepression

NeuroKappa Therapeutics Pipeline

DrugIndicationPhase
Salvinorin A Novel AnalogStroke (Neuroprotection)Pre-clinical
Dezocine & Associated ProductsOpioid Addiction Management / PainPre-clinical

Leadership Team at NeuroKappa Therapeutics

PF
Peter Fang, MD, MS
CEO
RL
Renyu Liu, MD, PhD
Founder
JG
John Grothusen, PhD
CSO (Chief Scientific Officer)
LF
Lei Fang, Esq, MD, PhD
Legal Counsel
YC
Yi-yen Chen, PhD
Business Development
View full NeuroKappa Therapeutics profile